A drug used with bortezomib and dexamethasone to treat multiple myeloma. It is used in patients who have already been treated with bortezomib and an immunomodulating agent. It is also being studied in [..]

A drug being studied in the treatment of cancer. It blocks enzymes needed for cells to grow and divide and may kill cancer cells. LBH589 may also prevent the growth of new blood vessels that tumors need to grow. It is a type of histone deacetylase inhibitor and a type of antiangiogenesis agent. Also called Faridak and panobinostat.